(Press-News.org) A new study shows that a woman's pre-pregnancy body fat (adiposity), in-pregnancy weight gain, and presence of gestational diabetes mellitus (GDM) can all combine to steeply increase the risk of giving birth to large-for-gestational age (LGA) babies to different degrees in white non-Hispanic, black non-Hispanic, White Hispanic, and Asian women, with the highest combined risk being in White non-Hispanic women. The research is published in the journal Diabetologia (the journal of the European Association for the Study of Diabetes) and is led by Dr Katherine Bowers and Dr Cuilin Zhang at the Eunice Kennedy Shriver National Institute of Child Health and Human Development at the National Institutes of Health (USA), and colleagues.
The race-specific joint effects of three major risk factors on risk of LGA births have previously not been comprehensively analysed. In this study, Bowers and colleagues analysed data from a major US study (the Consortium on Safe Labour study), comprising 105,985 pregnancies in the period 2002.
The researchers found that greater pre-pregnancy adiposity, pregnancy weight gain and GDM were all independently associated with increased risk of giving birth to an LGA infant across all races (except GDM among non-Hispanic whites), in both underweight and normal-weight women. Among non-Hispanic white (11-fold increased risk), non-Hispanic black (7-times) and Hispanic women (10 times), the three-factor joint effect was associated with substantially increased odds of LGA babies. However, for Asian women the joint effect of all three factors (five times increased risk) was approximately the same as any combination of two factors; whereas for Hispanic and non-Hispanic white women, the association with LGA delivery more than doubled when comparing three risk factors with two.
Asian women had the highest proportion of LGA births (12.0%) compared with black (10.6%), Hispanic 10.6%) and white non-Hispanic (9.7%) women. Asian women were also the most likely to have GDM (9.0%), compared with Hispanic women (6.0%) and white non-Hispanic and black non-Hispanic women (both 3.4%).
The authors say: "Variations in the influence of GDM and weight characteristics on LGA by race may be due to differences in metabolism exemplified by variation in body composition and/or genetics."
They further point out that regional fat distribution can vary between women across these races, and the study shows that baseline (pre-pregnancy) levels of overweight and obesity also varied widely depending on race. Black women had the highest levels (28% obese, 26% overweight), then Hispanic (18% obese, 27% overweight), then White non-Hispanic (15% obese, 20% overweight), and lastly Asian (9% obese, 14% overweight).
The authors conclude: "In this large multi-race/ethnicity cohort in the USA, we observed that GDM was significantly associated with risk of women giving birth to macrosomic and LGA infants, even among normal-weight and underweight women. More importantly, this association was significantly modified by prepregnancy BMI, pregnancy weight gain and race. The joint effects of pre-pregnancy obesity, weight gain during pregnancy and GDM on fetal growth also varied by race/ethnicity. These results suggest that a woman's race may be an important consideration when developing prevention strategies for excess fetal growth in women with GDM."
They add that it is important that the findings are replicated in future controlled studies before any concrete recommendations are issued. They say: "Given replicated evidence, especially white, but also black and Hispanic women would benefit greatly by focusing on a single factor, given the challenge of addressing pre-pregnancy weight and then weight gain and GDM together in pregnancy. Asian women would benefit most by addressing their GDM in addition to weight gain in pregnancy or entering pregnancy at a lower BMI."
### END
Pre-pregnancy body fat, in-pregnancy weight gain, and gestational diabetes combine to increase risk of high birthweight babies to differing degrees in white, black, Hispanic, and Asian women
2013-04-09
ELSE PRESS RELEASES FROM THIS DATE:
Environmental change triggers rapid evolution
2013-04-09
A University of Leeds-led study, published in the journal Ecology Letters, overturns the common assumption that evolution only occurs gradually over hundreds or thousands of years.
Instead, researchers found significant genetically transmitted changes in laboratory populations of soil mites in just 15 generations, leading to a doubling of the age at which the mites reached adulthood and large changes in population size. The results have important implications in areas such as disease and pest control, conservation and fisheries management because they demonstrate that ...
Adding intestinal enzyme to diets of mice appears to prevent, treat metabolic syndrome
2013-04-09
Feeding an intestinal enzyme to mice kept on a high-fat diet appears to prevent the development of metabolic syndrome – a group of symptoms associated with type 2 diabetes, cardiovascular disease and fatty liver – and to reduce symptoms in mice that already had the condition. In their report published online in PNAS Early Edition, Massachusetts General Hospital (MGH) investigators describe how dietary supplementation with intestinal alkaline phosphatase (IAP) reduced the inflammation believed to underlie metabolic syndrome by blocking a toxic molecule found on the surface ...
Nearly half of breast cancer patients at risk of having BRCA mutations not sent for genetic testing
2013-04-09
WASHINGTON, DC -- Only 53 percent of newly diagnosed breast cancer patients who were at high risk of carrying a BRCA 1 or BRCA 2 mutation – based on age, diagnosis, and family history of breast or ovarian cancer – reported that their doctors urged them to be tested for the genes, according to a research team from the Perelman School of Medicine at the University of Pennsylvania.
The findings, which will be presented during the American Association for Cancer Research Annual Meeting 2013 (Presentation #1358), were drawn from surveys completed by 2,258 women between 18 ...
Adding cetuximab to chemotherapy enables select patients with advanced colorectal cancer and liver metastasis to undergo surgery, extending survival by several months
2013-04-09
In this News Digest:
Summary of a study being published online April 8, 2013 in the Journal of Clinical Oncology, reports that adding cetuximab (Erbitux) to chemotherapy enabled previously inoperable patients to undergo surgery, tripling the rates of successful surgery for liver metastasis.
The combination of cetuximab and chemotherapy extended median overall survival for this population of patients by 10 months compared with chemotherapy alone.
Quote for attribution to Neal Meropol, MD, American Society of Clinical Oncology Cancer Communications Committee member ...
Month of birth impacts on immune system development
2013-04-09
Newborn babies' immune system development and levels of vitamin D have been found to vary according to their month of birth, according to new research.
The research, from scientists at Queen Mary, University of London and the University of Oxford, provides a potential biological basis as to why an individual's risk of developing the neurological condition multiple sclerosis (MS) is influenced by their month of birth. It also supports the need for further research into the potential benefits of vitamin D supplementation during pregnancy.
Around 100,000 people in the ...
Study finds key to calling back-up help when tumor-fighter p53 goes down
2013-04-09
WASHINGTON, D.C. – Tumor suppression, the family business of the sibling genes p53, p63 and p73, is undermined from within by the split personalities of p63 and p73, which each produce protein forms that not only block the work of the other two genes but also shut down its own cancer-stifling fraternal twin.
In a presentation at the AACR Annual Meeting 2013, scientists from The University of Texas MD Anderson Cancer Center demonstrate that tumor suppression can be restored in mice that lack p53 by knocking out the ∆N isoforms of p63 and p73 that interfere with tumor ...
AACR news: XL-184 (Cabozantinib) goes 12-for-12 in colorectal cancer explants
2013-04-09
The novel c-MET and VEGFR2 inhibitor, XL-184 (Cabozantinib), resulted in a significant decrease in tumor growth in 12 out of 12 colorectal cancer (CRC) patient-derived explants, with 8 of the explants exhibiting stable disease. The results of this preclinical work are presented at the AACR Annual Meeting 2013.
"With molecularly targeted agents, we typically see 3 or 4 CRC explant models with a significant decrease in tumor growth. Here we have a drug that was active in every explant we tested. It's really exciting," says John Arcaroli, PhD, investigator at the University ...
AACR news: Autophagy-addicted breast cancers killed by anti-malaria drug, chloroquine
2013-04-09
The process of autophagy cleans cells – they wrap up the bad stuff and then dispose of it. And so it stands to reason that inhibiting autophagy would make cancer cells less able to cleanse themselves of chemotherapy and so more susceptible to the drugs. That's what the traditional anti-malaria drug, chloroquine, does – it inhibits autophagy. Existing clinical trials are testing chloroquine/chemotherapy combinations against breast cancer.
Research presented at the AACR Annual Meeting 2013 shows that some breast cancer subtypes depend on autophagy more than others – and ...
Possible predictive biomarker for patients who may respond to autophagy inhibitors
2013-04-09
WASHINGTON, DC – Autophagy, the process by which cells that are starved for food resort to chewing up their own damaged proteins and membranes and recycling them into fuel, has emerged as a key pathway that cancer cells use to survive in the face of assault by chemotherapy and radiation. Using drugs to shut down that survival mechanism shows great promise, especially when combined with targeted agents and standard chemotherapies, but until recently, it has been unclear which patients' cancers would respond to that combination therapy.
A team led by researchers from the ...
Surface diffusion plays a key role in defining the shapes of catalytic nanoparticles
2013-04-09
Controlling the shapes of nanometer-sized catalytic and electrocatalytic particles made from noble metals such as platinum and palladium may be more complicated than previously thought.
Using systematic experiments, researchers have investigated how surface diffusion – a process in which atoms move from one site to another on nanoscale surfaces – affects the final shape of the particles. The issue is important for a wide range of applications that use specific shapes to optimize the activity and selectivity of nanoparticles, including catalytic converters, fuel cell ...